Novozymes A/S (NVZMF) Stock Price, News & Analysis

Company Overview

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Key Stats

• Today's Range: $67.30 to $67.30
• 50-Day Range: $53.68 to $67.30
• 52-Week Range: $53.55 to $71.52
• Volume: N/A
• Average Volume: 1,303 shs
• Market Capitalization: N/A
• P/E Ratio: 8.39
• Dividend Yield: 2.67%
• Price Target: N/A
• Consensus Rating: N/A

Novozymes A/S Stock Analysis - MarketRank™

Novozymes A/S scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Novozymes A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Novozymes A/S is 8.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of Novozymes A/S is 8.39, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 72.79.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 253.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Novozymes A/S has recently decreased by 1.60%, indicating that investor sentiment is improving.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Novozymes A/S has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Novozymes A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Novozymes A/S is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 253.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Novozymes A/S has recently decreased by 1.60%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.50

News Sentiment

Novozymes A/S has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Novozymes A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Novozymes A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 20.41% of the stock of Novozymes A/S is held by institutions.

NVZMF Stock Analysis - Frequently Asked Questions

How have NVZMF shares performed this year?

Novozymes A/S's stock was trading at $54.86 at the start of the year. Since then, NVZMF stock has increased by 22.7% and is now trading at $67.30.
View the best growth stocks for 2025 here.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) released its quarterly earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.43 by $2.06.

How do I buy shares of Novozymes A/S?

Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/20/2016
• Today: 5/13/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Specialty Chemicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NVZMF
• CIK: 1131345
• Web: www.novozymes.com
• Phone: (454) 446-0000
• Fax: N/A
• Employees: 10,452
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 8.39
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A